VentureNet Capital Group, Inc. is a business consulting and management company. The company is headquartered in Temecula, California. The company went IPO on 2001-10-22. The firm was crowd financed.
根据最新的财务报表(Form-10K),Virax Biolabs Group Ltd 的总资产为 $0,净亏损为 $0
VNTN 的关键财务比率是什么?
Virax Biolabs Group Ltd 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
VentureNet Capital Group Inc 的收入按细分市场或地理位置如何划分?
Virax Biolabs Group Ltd 最大收入来源是 ViraxClear and ViraxVet,在最近的收益报告中收入为 156,419。就地区而言, United Kingdom, Hong Kong, Singapore, China, British Virgin Islands 是 Virax Biolabs Group Ltd 的主要市场,收入为 156,419。